Business Development And Finance Consultant
D&A Advisors, Llc
AeroLeads people directory · profile
Tom Witt Email & Phone Number
Business Development and Finance Consultant
at
D&A Advisors, LLC
1 work email found
@atarabio.com
6 phones found area 805, 734, 303, and 310
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Business Development and Finance Consultant
Location
Carlsbad, California, United States
Who is Tom Witt? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Tom Witt is listed as Business Development and Finance Consultant at D&A Advisors, LLC, based in Carlsbad, California, United States. AeroLeads shows a work email signal at atarabio.com, phone signal with area code 805, 734, 303, 310, and a matched LinkedIn profile for Tom Witt.
Tom Witt previously worked as Vice President, Corporate Strategy & Business Development at Atara Biotherapeutics and Executive Director, Business Development & Strategy at Halozyme Therapeutics, Inc.. Tom Witt holds Bachelor Of Arts, Business Economics from Ucla.
Company email context
Email format at D&A Advisors, LLC
This section adds company-level context without repeating Tom Witt's masked contact details.
{first_initial}{last}@atarabio.com
86% confidence
AeroLeads found 1 current-domain work email signal for Tom Witt. Compare company email patterns before reaching out.
Profile bio
About Tom Witt
I am an accomplished, results-oriented, self-motivated senior-level executive with extensive finance, strategy and business/corporate development experience for global biopharmaceutical companies focused in therapeutics, technologies and devices. I combine a broad range of functional expertise with demonstrated leadership skills and the ability to build high-performing teams which enhances my ability to foster growth for dynamic organizations. My recent experiences in developing and managing corporate strategic initiatives through business development (sell-side and buy-side) have provided me with in-depth cross-functional perspectives on how to effectively drive strong performance for life sciences organizations. I am adept at cultivating and sustaining key internal and external relationships while bringing exceptional communication, interpersonal and leadership skills to an organization. My demonstrated skills include:- Financial Planning & Analysis- Business Development- Strategic Planning & Execution- Team Building and Leadership- Cross-Functional Collaboration- Financial Valuation- Due Diligence- Transaction Negotiations (Sell-Side and Buy-Side)- Alliance Management- Market Intelligence- Execution of Strategic Corporate Initiatives- Financial Decision Support I led all elements of a global collaboration and license agreement for Halozyme's ENHANZE drug delivery technology with a leading global biopharmaceutical company, with deal terms inclusive of $30M upfront, potential future milestones of up to $500M and mid-single digit royalties.
Listed skills include Financial Modeling, Forecasting, Cross Functional Team Leadership, Financial Analysis, and 47 others.
Current workplace
Tom Witt's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles
Tom Witt work experience
A career timeline built from the work history available for this profile.
Vice President, Corporate Strategy & Business Development
CurrentI am responsible for search, evaluation and in/out-bound transactions including strategic partnerships, licensing transactions, research collaborations and academic partnerships, as well as corporate strategy projects focused on value creation opportunities and long range planning.Successfully led various strategic transactions, including a Commercialization collaboration that out-licensed European and other ex-US territory rights to tab-cel®, an allogeneic T-cell immunotherapy therapeutic. Terms included a $45M upfront payment, $320M in regulatory and sales milestones and significant double-digit royalties.Led extensive follow-on deal process to out-license remaining global development and commercialization rights to tab-cel®, including the US market. Process resulted in an expanded collaboration for global rights, which included ~$30M upfront, $640M in regulatory and sales milestones as well as significant double-digit tiered royalties.Lead key initiatives focused on strategic deal rationale, screening, due diligence, valuation, competitive analyses, deal structuring, negotiations, management of advisors and reviews with executive management.Collaborate with R&D, Technical Operations, Regulatory, Commercial, Finance, Legal and Investor Relations to manage key company initiatives.
Dec 2020 - Present
Executive Director, Business Development & Strategy
As Head of the Halozyme BD & Strategy team, I was responsible for driving external licensing activities for the ENHANZE drug delivery technology through partner identification, opportunity assessment, creation of unique contracting and partnership strategies, oversight of due diligence, relationship management, negotiations, and execution of new deals. Successfully led sell-side efforts on a transaction with a mid-size pharmaceutical company that resulted in a $30M upfront payment, along with up to $500M in downstream milestones and royalties.Identified new potential ENHANZE partners through filtering of relevant databases, utilizing external resources, attending appropriate business development and technical conferences and closely monitoring industry developments, which led to generation of over 50 newly identified partner opportunities.Created and delivered ENHANZE presentations to prospective deal partners, covering introductions to the technology as well as deeper technical overviews which generated over 20 Non-Disclosure Agreements and 6 Material Transfer Agreements.Collaborated with functional leads to ensure alignment and effective communication for diligence activities with internal and external stakeholders, while leading deal partner negotiations, including the development of the value proposition, term sheet and management of the definitive agreement process.Prepared detailed market and company analyses along with financial modeling and deal valuation in support of several potential ENHANZE opportunities.Supported internal efforts to build ENHANZE brand and technology awareness with strategic publication and marketing plans, both for presentations at scientific conferences and publications in the research literature.
May 2019 - Jan 2020
Senior Director, Business Development & Strategy
Aug 2018 - May 2019
Sr. Director Of Corporate Development
Led the Avanir Corporate Development team focused on identification of in-licensing, out-licensing, acquisition, merger and/or co-promotion opportunities, coordination of cross-functional diligence activities, creation of detailed financial analyses, and deal negotiations. Cultivated Business Development projects, including buyer analyses, creation and delivery of pitch decks on Avanir/Otsuka capabilities, communications with external support teams (attorneys, investment bankers, consultants, strategic advisors) and presentation of business cases for executive/Board review. Led two consummated transactions, including a renegotiation of royalties for a pre-launch product, and a strategic long-term supply agreement for an innovative drug-device product. Collaborated with Otsuka to design new governance and operating procedures for global business development.Built financial models, including pro forma P&Ls and NPV estimates of product and company opportunities.Designed and implemented new cross-company process to align on strategic portfolio prioritization efforts across internal pipeline and external development opportunities.Managed Alliance Management responsibilities of Avanir partnerships, including negotiation of key supplier contracts, coordination of cross-company meetings, ensuring performance of license agreement obligations and development of strong cross-company working relationships. Developed, implemented and communicated new Market Intelligence platform to assist cross-functional leadership on keeping informed of company and product news across the neuroscience landscape, along with interpretations on strategic implications to Avanir’s commercial and development programs.
Jul 2017 - Aug 2018
Director Of Business Development
Jun 2015 - Jul 2017
Associate Director Of Business Development
Mar 2014 - Jun 2015
Head Of Sales & Marketing Finance
I was the lead finance business partner to the Global Sales & Marketing team for DERMAGRAFT, which included management of two-person staff responsible for financial planning, analysis, and presentations to senior leaders.Created new financial reporting processes and packages including weekly sales reports, monthly close packages, quarterly forecast deliverables and annual LRP/budget submissions.Collaborated with cross-functional leads to support investment decisions and business case presentations on multiple strategic initiatives to the Senior Leadership Team. Coordinated financial diligence on an acquisition opportunity, with responsibilities including a review and analysis of financial and market data and the creation of a P&L model used in the valuation negotiations.Developed key messages, deliverables and Q&A to support Investor Relations with quarterly earnings release.
Nov 2012 - Feb 2014
Finance Lead, Biosimilars
Developed processes to provide financial planning and analysis for newly launched Biosimilars division, including P&L preparation, cross-functional budgeting, forecasting and long range planning. Collaborated with Biosimilars Business Development lead on creation of potential partnership valuations, in-source and outsource cost/benefit reviews, and modeling of emerging market opportunities. Responsible for extensive financial modeling and presentations to external senior leadership which resulted in a $400M co-development partnership deal between Amgen and Watson Pharmaceuticals.
Jan 2011 - Nov 2012
Finance Senior Manager, R&D
Led strategic support for Oncology development team, including program specific NPV analyses, guidance on resource allocation and detailed clinical trial cost modeling.Drove monthly close process, budgeting, variance analysis and presentation of results.Developed comprehensive analyses of critical mid-stage pipeline drugs to inform senior management on key financial implications of advancing drugs to late-stage pipeline.
Jun 2009 - Jan 2011
Finance Senior Manager, Sales & Marketing
Managed two person team in support of $4 billion business unit, including oversight of monthly close process, annual forecasting and budgeting, and long range planning.
Mar 2005 - Jun 2009
Finance Manager, Sales & Marketing
Provided financial, analytical and decision support for Amgen’s first small molecule product launch (SENSIPAR) which enabled eventual progression to blockbuster status.
Aug 2003 - Mar 2005
2 education records
Tom Witt education
Bachelor Of Arts, Business Economics
Ucla
Mba, Finance, Strategy
University Of Michigan - Stephen M. Ross School Of Business
FAQ
Frequently asked questions about Tom Witt
Quick answers generated from the profile data available on this page.
What company does Tom Witt work for?
Tom Witt works for D&A Advisors, LLC.
What is Tom Witt's role at D&A Advisors, LLC?
Tom Witt is listed as Business Development and Finance Consultant at D&A Advisors, LLC.
What is Tom Witt's email address?
AeroLeads has found 1 work email signal at @atarabio.com for Tom Witt at D&A Advisors, LLC.
What is Tom Witt's phone number?
AeroLeads has found 6 phone signal(s) with area code 805, 734, 303, 310 for Tom Witt at D&A Advisors, LLC.
Where is Tom Witt based?
Tom Witt is based in Carlsbad, California, United States while working with D&A Advisors, LLC.
What companies has Tom Witt worked for?
Tom Witt has worked for D&A Advisors, Llc, Atara Biotherapeutics, Halozyme Therapeutics, Inc., Avanir Pharmaceuticals, and Shire.
How can I contact Tom Witt?
You can use AeroLeads to view verified contact signals for Tom Witt at D&A Advisors, LLC, including work email, phone, and LinkedIn data when available.
What schools did Tom Witt attend?
Tom Witt holds Bachelor Of Arts, Business Economics from Ucla.
What skills is Tom Witt known for?
Tom Witt is listed with skills including Financial Modeling, Forecasting, Cross Functional Team Leadership, Financial Analysis, Biotechnology, Managerial Finance, Leadership, and Management.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial